PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9306621-5	1997	Following danazol administration, marked and sustained increases were noted in Free Protein S, Antithrombin, and Protein C. Platelet CD62 (P-selectin) positivity which was elevated before therapy, decreased to assay threshold limits within five weeks.	Danazol	10-17	serpin family C member 1	Homo sapiens	95-107	
9306621-6	1997	Both Prothrombin Fragment 1.2 and thrombin-antithrombin complexes were elevated post danazol therapy indicating continued clearance of generated thrombin.	Danazol	85-92	serpin family C member 1	Homo sapiens	43-55	
7607583-3	1995	Based on reports of increases in the endogenous anticoagulants (protein C, protein S, antithrombin III and plasminogen) with synthetic androgen therapy, the patient was treated with danazol for 8 weeks.	Danazol	182-189	serpin family C member 1	Homo sapiens	86-102	
3942133-7	1986	The addition of danazol therapy led to a sustained rise in the antithrombin III level.	Danazol	16-23	serpin family C member 1	Homo sapiens	63-79	
1837483-8	1991	These data suggest that danazol is potentially useful therapy that may increase levels of natural anticoagulants in patients with thrombotic illnesses in which ATIII, PC and PS are low or normal.	Danazol	24-31	serpin family C member 1	Homo sapiens	160-165	
2313207-2	1990	Danazol (an attenuated synthetic androgen) already shown to be capable of compensating for a lack of certain antiproteases, was given in doses of 200 mg 3 times per day for 10 days, resulting in a rapid rise (mean 21.2%) in antithrombin III values.	Danazol	0-7	serpin family C member 1	Homo sapiens	224-240	
4060104-3	1985	Danazol, a 17-alkyl derivative of ethinyl testosterone, which has been used to treat other antiprotease deficiency states, was assessed in the management of two men with antithrombin deficiency.	Danazol	0-7	serpin family C member 1	Homo sapiens	170-182	
4060104-4	1985	In a dose of 600 mg a day danazol appeared to correct the antithrombin deficiency.	Danazol	26-33	serpin family C member 1	Homo sapiens	58-70	
4007636-0	1985	Treatment of familial antithrombin-III deficiency with danazol.	Danazol	55-62	serpin family C member 1	Homo sapiens	22-38	
4007636-1	1985	3 individuals from 2 unrelated families with recurrent thromboses and quantitative deficiencies of antithrombin III (AT-III) were treated with danazol, 600 mg daily for 4 months.	Danazol	143-150	serpin family C member 1	Homo sapiens	99-115	
4007636-1	1985	3 individuals from 2 unrelated families with recurrent thromboses and quantitative deficiencies of antithrombin III (AT-III) were treated with danazol, 600 mg daily for 4 months.	Danazol	143-150	serpin family C member 1	Homo sapiens	117-123	
6150297-0	1984	Danazol raises antithrombin III levels in cases of familial deficiency.	Danazol	0-7	serpin family C member 1	Homo sapiens	15-31	
489712-7	1979	3) Transferrin, antithrombin III, prothrombin, and plasminogen showed marked increases after administration of danazol and during pregnancy.	Danazol	111-118	serpin family C member 1	Homo sapiens	16-32